Skip to main content

Table 5 BCG induced cytokine production by PBMC

From: Thalidomide Treatment Reduces Tumor Necrosis Factor α Production and Enhances Weight Gain in Patients with Pulmonary Tuberculosis

  Thalidomide treatment (n = 18)a Placebo treatment (n = 8)a
Cytokine Pre Mid Post Pre Mid Post
TNFα 1871 ± 601 1274 ± 565 2504 ± 793 1875 ± 797 2283 ± 775 1815 ± 790
IFNγ 218 ± 122 549 ± 330 218 ± 58 197 ± 69 236 ± 79 231 ± 55
  1. TNFα and IFNγ levels were assayed by ELISA (as described in Materials and Methods) in the supernatants of PBMCs obtained from patients treated with either thalidomide or placebo. Results are expressed as pg/ml. aThe means for the number of patients shown in the parentheses ± SEM are given.